BioSpace News Archive

Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on innovative, minimally invasive device-based solutions for cardiovascular conditions, today announced enrollment of the first patients in an FDA-approved best-in-class pivotal clinical trial.

Baxter Canada, a leader in nutrition therapy, today announced Health Canada approval of OLIMEL 7.6% and OLIMEL 7.6% E (amino acids, dextrose, lipids with/without electrolytes, injectable emulsion) for parenteral nutrition for adults when oral or enteral nutrition is impossible, insufficient or contraindicated.

Leading global technology services provider, Xpanxion, a UST Global Group company, is excited and extremely pleased to announce the opening of its newest Rural Delivery and Services Center in Sidney, Nebraska.

Ampersand Capital Partners, together with the management team of NEOMED-LABS and the NEOMED Institute, announced today that Ampersand has partnered with management in the acquisition of NEOMED-LABS from its not-for-profit founder and parent, the NEOMED Institute.

Comar, a leading designer and manufacturer of quality healthcare packaging products, introduces the new SecureCap® QuarterLoc™ child resistant closure, a one-piece push-and-turn bottle closure that requires only a quarter turn to apply or remove.

Chinese online B2C pharmacy and healthcare services platform Jianke today announced that it has successfully closed a USD130 million Series B financing round, led by GTJA Investment Group, with participation from HBM Healthcare Investments and Crescent Point.

The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for esketamine nasal spray.

Sickle Cell disease is a condition that affects people around the world. In Georgia there are more than 7,000 people living with Sickle Cell.

The WIRB-Copernicus Group®'s (WCG™) Clinical Services Division has partnered with Inspire, the largest online community of patients and caregivers, to make clinical research more accessible to all patients, especially those suffering from rare and genetic-based diseases.

Perimenopause--the hormonal “roller-coaster” years preceding menopause--can be a bumpy ride for many women. While symptoms commonly begin around age 42, they can occur earlier or with cancer treatment or hysterectomy. Barb DePree, MD, OB/GYN, Lakeshore Health Partners and Founder of MiddlesexMD, helps women identify early transition signs and prepare for the change of life.